Profile data is unavailable for this security.
About the company
NanJing Pharmaceutical Company Limited is a China-based company principally engaged in the pharmaceutical distribution business. The Company's principal businesses include the pharmaceutical wholesale, pharmaceutical retail, pharmaceutical-Internet + business, as well as the pharmaceutical third-party logistics services. The Company mainly conducts its business in domestic market.
- Revenue in CNY (TTM)53.33bn
- Net income in CNY565.72m
- Incorporated1994
- Employees5.06k
- LocationNanJing Pharmaceutical Co LtdBuilding 8(Nanjng Intrntnl Hlth Indl Prk,No.1 YjXiaoxingli, Yuhuatai DistrictNANJING 210012ChinaCHN
- Phone+86 2 584552601
- Fax+86 2 584552601
- Websitehttps://www.njyy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shanghai New World Co Ltd | 1.08bn | 31.68m | 3.95bn | 1.23k | 124.59 | 0.9307 | -- | 3.67 | 0.049 | 0.049 | 1.66 | 6.55 | 0.1886 | 4.13 | 7.45 | 873,336.10 | 0.5592 | 1.32 | 0.743 | 1.80 | 34.67 | 32.05 | 2.97 | 5.35 | 1.43 | -- | 0.1214 | 48.81 | -27.07 | -22.41 | -174.90 | -- | 35.37 | -32.24 |
NanJing Pharmaceutical Co Ltd | 53.33bn | 565.72m | 5.83bn | 5.06k | 10.23 | 0.914 | -- | 0.1093 | 0.435 | 0.435 | 41.02 | 4.87 | 1.66 | 9.24 | 3.39 | 10,544,120.00 | 2.16 | 2.24 | 8.38 | 9.34 | 6.11 | 6.50 | 1.30 | 1.26 | 1.07 | 2.93 | 0.6023 | 30.50 | 11.30 | 11.76 | 17.91 | 20.71 | -8.91 | 9.24 |
Guangxi LiuYao Group Co Ltd | 20.45bn | 800.82m | 7.62bn | 5.16k | 9.52 | 1.17 | -- | 0.3729 | 2.21 | 2.21 | 56.44 | 17.97 | 1.02 | 7.66 | 1.96 | 3,961,076.00 | 4.36 | 5.37 | 11.45 | 12.66 | 11.26 | 11.68 | 4.27 | 4.48 | 1.26 | 6.34 | 0.5641 | 30.45 | 11.19 | 15.06 | 24.42 | 11.81 | -0.6923 | 8.57 |
Data as of Mar 28 2024. Currency figures normalised to NanJing Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
GF Fund Management Co., Ltd.as of 30 Jun 2023 | 6.45m | 0.62% |
Zhong Ou Asset Management Co., Ltdas of 30 Jun 2023 | 4.83m | 0.46% |
HuaAn Fund Management Co., Ltd.as of 30 Jun 2023 | 4.60m | 0.44% |
Lion Fund Management Co., Ltd.as of 30 Jun 2023 | 2.51m | 0.24% |
China Fund Management Co., Ltd.as of 30 Jun 2023 | 1.98m | 0.19% |
The Vanguard Group, Inc.as of 29 Feb 2024 | 1.88m | 0.18% |
Gfund Management Co., Ltd.as of 30 Jun 2023 | 1.58m | 0.15% |
Orient Securities Asset Management Co. Ltd.as of 30 Jun 2023 | 959.60k | 0.09% |
China Merchants Fund Management Co., Ltd.as of 30 Jun 2023 | 500.70k | 0.05% |
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2023 | 121.00k | 0.01% |
More ▼
Data from 30 Jun 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.